← Leaderboards
Kevin D. O'Brien
University Of Washington
$6,249,245
Attributed
$9,287,125
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $979.3K · FY2008–23$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$9,287,125 · 5
By mechanism
R01$6,462,619 · 2
P01$2,283,758 · 2
R21$540,748 · 1
Top collaborators
- Rong Tian10 shared
- Renee C Leboeuf5 shared
Most similar at University Of Washington
Same institution · by research overlap
- Jay W Heinecke$34,087,651
- Jenny E. Kanter$4,494,120
- Xue-Qiao Zhao$6,599,357
- Evan D Kharasch$17,406,013
- Albert R La Spada$44,944,106
Others in their field
Top investigators on “Tissues”
- David Heimbrook · Leidos Biomedical Research, Inc.$346,311,904
- Lawrence Corey · Fred Hutchinson Cancer Center$230,011,824
- Larry Arthur$159,140,370
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Judith S. Currier · University Of California Los Angeles$138,805,403
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$138,805,403
Research focus
TissuesCellsBaseArterial Fatty StreakRandomizedParticipantAtherosclerosisPreventInflammatoryProteinsInflammatory ResponseInflammationEnrollmentHeart FailureHeartAnimal ModelCardiacBloodNicotinamide-Beta-RibosideMitochondrial DysfunctionMorphologyOralImageImmunohistochemistry
Grant awards (25)
Mechanistic Studies of NAD+/NADH in Human Heart Failure$749,718
R01 · FY2023 · HL · contact PI
Mechanistic Studies of NAD+/NADH in Human Heart Failure$181,823
R01 · FY2023 · HL · contact PI
Mechanistic Studies of NAD+/NADH in Human Heart Failure$773,881
R01 · FY2022 · HL · contact PI
Energy metabolism and NAD+/NADH in Right Ventricular Failure$205,417
R01 · FY2022 · HL · contact PI
Mechanistic Studies of NAD+/NADH in Human Heart Failure$773,881
R01 · FY2021 · HL · contact PI
Mechanistic Studies of NAD+/NADH in Human Heart Failure$773,881
R01 · FY2020 · HL · contact PI
Mechanistic Studies of NAD+/NADH in Human Heart Failure$771,937
R01 · FY2019 · HL · contact PI
Core C: Tissue and Imaging Core$195,112
P01 · FY2019 · HL · contact PI
Core C: Tissue and Imaging Core$200,164
P01 · FY2018 · HL · contact PI
Core C: Tissue and Imaging Core$200,154
P01 · FY2017 · HL · contact PI
Safety and Tolerability of the Nutritional Supplement, Nicotinamide Riboside, in Systolic Heart Failure$193,125
R21 · FY2017 · HL
Core C: Tissue and Imaging Core$191,927
P01 · FY2016 · HL · contact PI
Safety and Tolerability of the Nutritional Supplement, Nicotinamide Riboside, in Systolic Heart Failure$231,750
R21 · FY2015 · HL
Core C: Tissue and Imaging Core$191,927
P01 · FY2015 · HL · contact PI
Safety and Tolerability of the Nutritional Supplement, Nicotinamide Riboside, in Systolic Heart Failure$115,873
R21 · FY2015 · HL
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH$413,145
R01 · FY2012 · HL · contact PI
Core B and Tissue Core$260,895
P01 · FY2012 · HL · contact PI
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH$440,457
R01 · FY2011 · HL · contact PI
Core B and Tissue Core$260,896
P01 · FY2011 · HL · contact PI
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH$446,687
R01 · FY2010 · HL · contact PI
Core B and Tissue Core$260,896
P01 · FY2010 · HL · contact PI
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH$483,730
R01 · FY2009 · HL · contact PI
Core B and Tissue Core$260,896
P01 · FY2009 · HL · contact PI
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH$448,062
R01 · FY2008 · HL · contact PI
Core B and Tissue Core$260,891
P01 · FY2008 · HL · contact PI